A Kyoto University research team said Monday it will begin a clinical test this week using induced pluripotent stem cells to treat Parkinson's disease, in what will be the world's first application of iPS technology to the progressive neurological disorder.
The team led by Jun Takahashi, a professor at the university's Center for iPS Cell Research and Application, has received government approval and is soliciting seven patients to participate in the trial, which will be conducted at Kyoto University Hospital.
The research team said one of the patients taking part in the study will be selected from those being treated at Kyoto University Hospital.